Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors

Margit Fuchs, Peter Hutzler, Ingrid Brunner, Jürgen Schlegel, Jörg Mages, Ute Reuning, Sandra Hapke, Justus Duyster, Setsuo Hirohashi, Takuya Genda, Michiie Sakamoto, Florian Überall, Heinz Höfler, Karl Friedrich Becker, Birgit Luber

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Diffuse-type gastric and lobular breast cancers are characterized by frequent mutations in the cell adhesion molecule E-cadherin. Here we report that tumor-associated mutations of E-cadherin enhanced random cell movement of transfected MDA-MB-435S mammary carcinoma cells as compared to wild-type (wt) E-cadherin-expressing cells. The mutations included in frame deletions of exons 8 or 9 and a point mutation in exon 8 which all affect putative calcium-binding sites within the linker region of the second and third extracellular domain. Motility enhancement by mutant E-cadherin was investigated by time-lapse laser scanning microscopy. Increased cell motility stimulated by mutant E-cadherin was influenced by cell-matrix interactions. The motility-increasing activity of mutant E-cadherin was blocked by application of pharmacological inhibitors of epidermal growth factor receptor and phosphatidylinositol (PI) 3-kinase. Investigation of the activation status of PI 3-kinase and the downstream signaling molecules Akt/protein kinase B and MAP kinase p44/42 showed that these kinases are not more strongly activated in mutant E-cadherin-expressing cells than in wt E-cadherin-expressing cells. Instead, the basal level of PI 3-kinase is necessary for mutant E-cadherin-enhanced cell motility. Our data suggest a critical role of E-cadherin mutations for the fine tuning of tumor cell motility.

Original languageEnglish
Pages (from-to)129-141
Number of pages13
JournalExperimental Cell Research
Volume276
Issue number2
DOIs
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Phosphatidylinositol 3-Kinase
Cadherins
Epidermal Growth Factor Receptor
Neoplasms
Cell Movement
Mutation
Exons
Breast Neoplasms
Proto-Oncogene Proteins c-akt
Mitogen-Activated Protein Kinase Kinases
Cell Adhesion Molecules
Point Mutation
Confocal Microscopy
Cell Communication
Protein Kinases
Stomach
Phosphotransferases
Binding Sites

Keywords

  • Akt/protein kinase B
  • Cell motility
  • E-cadherin
  • EGF receptor
  • MAP kinase
  • PI 3-kinase

ASJC Scopus subject areas

  • Cell Biology

Cite this

Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors. / Fuchs, Margit; Hutzler, Peter; Brunner, Ingrid; Schlegel, Jürgen; Mages, Jörg; Reuning, Ute; Hapke, Sandra; Duyster, Justus; Hirohashi, Setsuo; Genda, Takuya; Sakamoto, Michiie; Überall, Florian; Höfler, Heinz; Becker, Karl Friedrich; Luber, Birgit.

In: Experimental Cell Research, Vol. 276, No. 2, 2002, p. 129-141.

Research output: Contribution to journalArticle

Fuchs, M, Hutzler, P, Brunner, I, Schlegel, J, Mages, J, Reuning, U, Hapke, S, Duyster, J, Hirohashi, S, Genda, T, Sakamoto, M, Überall, F, Höfler, H, Becker, KF & Luber, B 2002, 'Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors', Experimental Cell Research, vol. 276, no. 2, pp. 129-141. https://doi.org/10.1006/excr.2002.5518
Fuchs, Margit ; Hutzler, Peter ; Brunner, Ingrid ; Schlegel, Jürgen ; Mages, Jörg ; Reuning, Ute ; Hapke, Sandra ; Duyster, Justus ; Hirohashi, Setsuo ; Genda, Takuya ; Sakamoto, Michiie ; Überall, Florian ; Höfler, Heinz ; Becker, Karl Friedrich ; Luber, Birgit. / Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors. In: Experimental Cell Research. 2002 ; Vol. 276, No. 2. pp. 129-141.
@article{8b01384ce7294361b0130673fdb251c3,
title = "Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors",
abstract = "Diffuse-type gastric and lobular breast cancers are characterized by frequent mutations in the cell adhesion molecule E-cadherin. Here we report that tumor-associated mutations of E-cadherin enhanced random cell movement of transfected MDA-MB-435S mammary carcinoma cells as compared to wild-type (wt) E-cadherin-expressing cells. The mutations included in frame deletions of exons 8 or 9 and a point mutation in exon 8 which all affect putative calcium-binding sites within the linker region of the second and third extracellular domain. Motility enhancement by mutant E-cadherin was investigated by time-lapse laser scanning microscopy. Increased cell motility stimulated by mutant E-cadherin was influenced by cell-matrix interactions. The motility-increasing activity of mutant E-cadherin was blocked by application of pharmacological inhibitors of epidermal growth factor receptor and phosphatidylinositol (PI) 3-kinase. Investigation of the activation status of PI 3-kinase and the downstream signaling molecules Akt/protein kinase B and MAP kinase p44/42 showed that these kinases are not more strongly activated in mutant E-cadherin-expressing cells than in wt E-cadherin-expressing cells. Instead, the basal level of PI 3-kinase is necessary for mutant E-cadherin-enhanced cell motility. Our data suggest a critical role of E-cadherin mutations for the fine tuning of tumor cell motility.",
keywords = "Akt/protein kinase B, Cell motility, E-cadherin, EGF receptor, MAP kinase, PI 3-kinase",
author = "Margit Fuchs and Peter Hutzler and Ingrid Brunner and J{\"u}rgen Schlegel and J{\"o}rg Mages and Ute Reuning and Sandra Hapke and Justus Duyster and Setsuo Hirohashi and Takuya Genda and Michiie Sakamoto and Florian {\"U}berall and Heinz H{\"o}fler and Becker, {Karl Friedrich} and Birgit Luber",
year = "2002",
doi = "10.1006/excr.2002.5518",
language = "English",
volume = "276",
pages = "129--141",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors

AU - Fuchs, Margit

AU - Hutzler, Peter

AU - Brunner, Ingrid

AU - Schlegel, Jürgen

AU - Mages, Jörg

AU - Reuning, Ute

AU - Hapke, Sandra

AU - Duyster, Justus

AU - Hirohashi, Setsuo

AU - Genda, Takuya

AU - Sakamoto, Michiie

AU - Überall, Florian

AU - Höfler, Heinz

AU - Becker, Karl Friedrich

AU - Luber, Birgit

PY - 2002

Y1 - 2002

N2 - Diffuse-type gastric and lobular breast cancers are characterized by frequent mutations in the cell adhesion molecule E-cadherin. Here we report that tumor-associated mutations of E-cadherin enhanced random cell movement of transfected MDA-MB-435S mammary carcinoma cells as compared to wild-type (wt) E-cadherin-expressing cells. The mutations included in frame deletions of exons 8 or 9 and a point mutation in exon 8 which all affect putative calcium-binding sites within the linker region of the second and third extracellular domain. Motility enhancement by mutant E-cadherin was investigated by time-lapse laser scanning microscopy. Increased cell motility stimulated by mutant E-cadherin was influenced by cell-matrix interactions. The motility-increasing activity of mutant E-cadherin was blocked by application of pharmacological inhibitors of epidermal growth factor receptor and phosphatidylinositol (PI) 3-kinase. Investigation of the activation status of PI 3-kinase and the downstream signaling molecules Akt/protein kinase B and MAP kinase p44/42 showed that these kinases are not more strongly activated in mutant E-cadherin-expressing cells than in wt E-cadherin-expressing cells. Instead, the basal level of PI 3-kinase is necessary for mutant E-cadherin-enhanced cell motility. Our data suggest a critical role of E-cadherin mutations for the fine tuning of tumor cell motility.

AB - Diffuse-type gastric and lobular breast cancers are characterized by frequent mutations in the cell adhesion molecule E-cadherin. Here we report that tumor-associated mutations of E-cadherin enhanced random cell movement of transfected MDA-MB-435S mammary carcinoma cells as compared to wild-type (wt) E-cadherin-expressing cells. The mutations included in frame deletions of exons 8 or 9 and a point mutation in exon 8 which all affect putative calcium-binding sites within the linker region of the second and third extracellular domain. Motility enhancement by mutant E-cadherin was investigated by time-lapse laser scanning microscopy. Increased cell motility stimulated by mutant E-cadherin was influenced by cell-matrix interactions. The motility-increasing activity of mutant E-cadherin was blocked by application of pharmacological inhibitors of epidermal growth factor receptor and phosphatidylinositol (PI) 3-kinase. Investigation of the activation status of PI 3-kinase and the downstream signaling molecules Akt/protein kinase B and MAP kinase p44/42 showed that these kinases are not more strongly activated in mutant E-cadherin-expressing cells than in wt E-cadherin-expressing cells. Instead, the basal level of PI 3-kinase is necessary for mutant E-cadherin-enhanced cell motility. Our data suggest a critical role of E-cadherin mutations for the fine tuning of tumor cell motility.

KW - Akt/protein kinase B

KW - Cell motility

KW - E-cadherin

KW - EGF receptor

KW - MAP kinase

KW - PI 3-kinase

UR - http://www.scopus.com/inward/record.url?scp=18544365655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544365655&partnerID=8YFLogxK

U2 - 10.1006/excr.2002.5518

DO - 10.1006/excr.2002.5518

M3 - Article

VL - 276

SP - 129

EP - 141

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -